Home › Funds › WELCH & FORBES LLC › VRTX

WELCH & FORBES LLC position in VRTX

VERTEX PHARMACEUTICALS INC · Health Care

WELCH & FORBES LLC reported holding 219,564 shares of VRTX (VERTEX PHARMACEUTICALS INC) in its Q3 2026 13F filing — a position valued at US$114.8M, representing 1.38% of its reported portfolio and ranking #20 among its reported holdings. WELCH & FORBES LLC has disclosed VRTX holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)219.56K sh
Reported value held$114.79M
Portfolio Weight1.38%
First reportedQ3 2023
Last changeReduce
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How WELCH & FORBES LLC's VRTX position evolved

WELCH & FORBES LLC first disclosed a stake in VRTX in Q3 2023 at 185,070 shares (US$64.4M). The position peaked in Q3 2026 at 219,564 shares, worth US$114.8M. Across 13 filings, WELCH & FORBES LLC increased the stake 10 time(s), trimmed it 2 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 219,564 shares valued at US$114.8M — a reduction of -1,740 shares quarter over quarter..

Quarter by quarter

QuarterSharesValueChange
Q3 2023 185.07K $64.36M New
Q4 2023 188.39K $76.65M Add
Q1 2024 192.94K $80.65M Add
Q2 2024 194.90K $94.29M Add
Q3 2024 196.62K $91.44M Add
Q4 2024 197.78K $79.65M Add
Q1 2025 207.64K $100.67M Add
Q2 2025 217.24K $96.72M Add
Q3 2025 220.35K $86.30M Add
Q4 2025 218.20K $98.92M Reduce
Q1 2026 219.67K $98.09M Add
Q2 2026 221.30K $109.93M Add
Q3 2026 219.56K $114.79M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About VRTX and 13F data

VRTX (VERTEX PHARMACEUTICALS INC) is a Health Care company. 32 other funds we track also report a position in VRTX — the largest reported positions include Capital World Investors (US$13.58B), Capital World Investors (US$12.97B), Capital Research Global Investors (US$9.68B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding VRTX

All VRTX fund holders →

FAQ

How long has WELCH & FORBES LLC held VRTX?

WELCH & FORBES LLC has disclosed VRTX holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is WELCH & FORBES LLC's current position in VRTX?

As of Q3 2026, WELCH & FORBES LLC holds 219.56K shares of VRTX (VERTEX PHARMACEUTICALS INC), valued at $114.79M, representing 1.38% of its reported portfolio and ranking #20.

Has WELCH & FORBES LLC been buying or selling VRTX?

In the latest 13F filing (Q3 2026), WELCH & FORBES LLC reduced its position in VRTX. The position peaked in Q3 2026 at 219.56K shares.

Which other funds hold VRTX?

Other major institutional holders of VRTX include Capital World Investors, Capital World Investors, Capital Research Global Investors, among 32 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.